30: IT Just Got a Whole Lot Better – Vaginal Estrogen, the FDA, and What Changes Now Part 3

Episode 30 Connect Pillar

IT Just Got a Whole Lot Better: Vaginal Estrogen, the FDA, and What Changes Now Part 3

This is the finale of my three-part series on sexual health in perimenopause, and it is the one I have been most excited to share. This episode lives in the Connect pillar of the Perimenopause Matrix, and it covers what I genuinely consider the most underused and underappreciated tool in the entire perimenopause toolkit: vaginal estrogen.

We start with anatomy, because I believe you cannot advocate for yourself if you do not have the vocabulary. I walk through the structures of the vulva and vagina, what each one does, and why all of it is estrogen-sensitive. We talk about discharge and cervical mucus, two things that are completely normal and almost never discussed clearly, including why your vagina does not need your help cleaning itself and why it should absolutely not smell like flowers.

From there we get into what estrogen decline actually does to all of that tissue: the changes to the labia, the clitoris, the urethral tissue, and the vaginal walls. This is Genitourinary Syndrome of Menopause, GSM, and I explain why it is not just a sexual health issue. It affects urinary health, daily comfort, and quality of life whether you are sexually active or not.

I share two client stories that I think will feel very familiar. I cover the full history of the black box warning that kept millions of women away from vaginal estrogen for over two decades, what the FDA changed in November 2025, and what is coming next. And I close with my own personal experience, because I think the abstract becomes a lot more useful when it is concrete.

“That is how quietly GSM can develop. You adapt. You work around it. You think this is just what it is now. And then something changes and you realize how much you had normalized without ever naming it. You do not have to normalize it.”

What You’ll Learn

  • The correct anatomy of the vulva and vagina and why knowing the difference matters for your healthcare conversations
  • What GSM is, how it affects the vulva, vagina, and urinary tract, and why it is progressive if left unaddressed
  • Why vaginal estrogen does not affect blood estrogen levels and has a completely different safety profile from systemic hormone therapy
  • What the FDA changed in November 2025, why it matters, and what is coming next with the OTC push
  • Why vaginal estrogen is safe for most vulva owners, including many breast cancer survivors, and how to have the conversation with your provider

Key Takeaways

  • Get a hand mirror and look. Knowing your baseline is how you notice changes. You cannot advocate for what you cannot see or name.
  • Your vagina is self-cleaning. No douching, no internal products, no scented wipes or sprays. Gentle unscented soap on the vulva only.
  • Scented vaginal products contain endocrine-disrupting fragrance chemicals. Your vagina should not smell like flowers. That is a marketing invention, not a health standard.
  • If you are experiencing recurrent UTIs, vaginal dryness, changes in arousal or orgasm, urinary urgency, or discomfort during sex, vaginal estrogen is worth asking about. You do not have to be in crisis to start the conversation.
  • Print Dr. Rachel Rubin’s prescriber guide at rachelrubinmd.com/gsm and bring it to your next appointment if your provider is not current on the updated guidance.

The Perimenopause Matrix Lab Review

I’ll analyze your recent labs through the lens of perimenopause and create a personalized roadmap showing you exactly which pillar to focus on first. No more guessing. Just clear answers and one actionable next step.

Learn more about the Matrix Lab Review

Perimenopause Symptom Decoder

Download the free guide and get clarity on what’s happening in your body. You’re not crazy. You’re not broken. You’re not alone.

Get the free Perimenopause Decoder

Full Transcript